NIO
NIO Inc.
NIO has the edge over THCH overall, supported by stronger fundamentals and lower modeled downside.
THCH
TH International Limited
THCH offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
THCH Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Unavailable |
THCH's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
THCH PE Valuation
THCH has no meaningful PE right now: it lost money over the past year.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
NIO has the edge over THCH on the outlook, with more favorable earnings and revenue expectations.
THCH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect THCH's earnings, revenue and profitability to hold roughly steady.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO has the edge over THCH on earnings, with more consistent year-over-year improvement.
THCH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$2.33 | -$0.70 |
| Q1 2026 | -$2.23 | -$0.73 |
| Q4 2025 | -$1.99 | -$0.08 |
| Q3 2025 | -$1.56 | +$1.19 |
| Q2 2025 | -$1.63 | +$1.47 |
| Q1 2025 | -$1.50 | +$2.51 |
| Q4 2024 | -$1.91 | +$2.62 |
| Q3 2024 | -$2.75 | +$2.00 |
THCH is still losing money, but far less than before: $2.33 per share over the past year, against $5.40 at its worst in mid-2023.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO has the edge over THCH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO has the edge over THCH on profitability, with a higher operating margin.
THCH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.9M | -22% |
| Q1 2026 | $38.3M | -15% |
| Q4 2025 | $45.7M | -8.5% |
| Q3 2025 | $53.7M | -0.4% |
| Q2 2025 | $52.4M | -4.9% |
| Q1 2025 | $45.1M | -9.5% |
| Q4 2024 | $49.9M | -15% |
| Q3 2024 | $54M | -17% |
THCH's revenue has slid since its 2023 peak: $41M last quarter, down 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -20% | -9.2 points |
| Q1 2026 | -26% | -2.2 points |
| Q4 2025 | -28% | +2.1 points |
| Q3 2025 | -15% | -4.6 points |
| Q2 2025 | -11% | +4 points |
| Q1 2025 | -24% | +13 points |
| Q4 2024 | -30% | +29 points |
| Q3 2024 | -11% | +23 points |
THCH's operating margin was −20% last quarter, down 9.2 points from the same quarter a year ago.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
THCH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $5.1M | +$5.3M |
| Q1 2026 | -$3.5M | -$3.5M |
| Q4 2025 | -$11.3M | -$6.5M |
| Q3 2025 | -$257.1K | +$1.7M |
| Q2 2025 | -$176.3K | -104% |
| Q1 2025 | -$32.9K | +$4M |
| Q4 2024 | -$4.7M | +$51.2M |
| Q3 2024 | -$2M | +$2.6M |
THCH has the edge over NIO on cash flow, with more consistent year-over-year improvement.
NIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +15.6M shares |
| 1 year | +12% | +267M shares |
| 3 years | +51% | +844M shares |
| 5 years | +60% | +933M shares |
| Available history | +143% | +1.5B shares |
NIO has 2.5B diluted shares, up 12% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NIO hasn't bought back shares in the past year.
THCH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -4.3K shares |
| 3 years | +6.7% | +2M shares |
| 5 years | +21% | +5.6M shares |
| Available history | +21% | +5.6M shares |
THCH has the edge over NIO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
THCH hasn't bought back shares in the past year.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
THCH Net Leverage
THCH's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
THCH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.7 | Neutral |
| Stochastic | 33.1 | Neutral |
THCH's weekly RSI is 42 (neutral) and its Stochastic is 33 (neutral).
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
THCH PE vs Consumer Cyclical Sector
THCH has no meaningful PE right now: it lost money over the past year.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
THCH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.17 | 6% above |
| 20 week MA | $1.40 | 11% below |
| 50 week MA | $1.79 | 31% below |
| 100 week MA | $2.32 | 47% below |
| 200 week MA | $6.07 | 80% below |
THCH has the edge over NIO on trend strength, trading above more of its moving averages.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO has the edge over THCH on returns for 2026, with the stronger performance.
THCH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $49.1 | $48.9 | -0.4% |
| 2022 | $48.9 | $15.7 | -68% |
| 2023 | $15.7 | $8.75 | -44% |
| 2024 | $8.75 | $3.73 | -57% |
| 2025 | $3.73 | $2.19 | -41% |
| 2026 YTD | $2.19 | $1.24 | -43% |
THCH has finished every year since 2021 lower, and it's down 43% so far in 2026.